nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP2D6—Fingolimod—multiple sclerosis	0.0744	0.239	CbGbCtD
Maprotiline—ABCB1—Methylprednisolone—multiple sclerosis	0.0509	0.163	CbGbCtD
Maprotiline—ABCB1—Mitoxantrone—multiple sclerosis	0.0371	0.119	CbGbCtD
Maprotiline—ABCB1—Betamethasone—multiple sclerosis	0.0331	0.106	CbGbCtD
Maprotiline—ABCB1—Prednisolone—multiple sclerosis	0.0326	0.105	CbGbCtD
Maprotiline—ABCB1—Prednisone—multiple sclerosis	0.0308	0.0989	CbGbCtD
Maprotiline—HTR2A—trigeminal nucleus—multiple sclerosis	0.0296	0.169	CbGeAlD
Maprotiline—ABCB1—Dexamethasone—multiple sclerosis	0.0192	0.0617	CbGbCtD
Maprotiline—CYP2D6—Dexamethasone—multiple sclerosis	0.0181	0.0582	CbGbCtD
Maprotiline—ABCB1—Methotrexate—multiple sclerosis	0.0155	0.0496	CbGbCtD
Maprotiline—HTR7—pons—multiple sclerosis	0.00879	0.0501	CbGeAlD
Maprotiline—HTR2A—trigeminal nerve—multiple sclerosis	0.00778	0.0444	CbGeAlD
Maprotiline—SLC6A3—nerve—multiple sclerosis	0.00586	0.0334	CbGeAlD
Maprotiline—HTR7—peripheral nervous system—multiple sclerosis	0.00585	0.0333	CbGeAlD
Maprotiline—HTR2A—pons—multiple sclerosis	0.00548	0.0312	CbGeAlD
Maprotiline—SLC6A2—nerve—multiple sclerosis	0.00473	0.027	CbGeAlD
Maprotiline—HTR7—nerve—multiple sclerosis	0.00456	0.026	CbGeAlD
Maprotiline—DRD2—nerve—multiple sclerosis	0.00431	0.0246	CbGeAlD
Maprotiline—HTR2A—pineal body—multiple sclerosis	0.00391	0.0223	CbGeAlD
Maprotiline—HTR2A—peripheral nervous system—multiple sclerosis	0.00365	0.0208	CbGeAlD
Maprotiline—HTR2A—nerve—multiple sclerosis	0.00284	0.0162	CbGeAlD
Maprotiline—SLC6A3—brainstem—multiple sclerosis	0.00252	0.0143	CbGeAlD
Maprotiline—CHRM4—nervous system—multiple sclerosis	0.00246	0.014	CbGeAlD
Maprotiline—HTR2C—brainstem—multiple sclerosis	0.00243	0.0139	CbGeAlD
Maprotiline—CHRM4—central nervous system—multiple sclerosis	0.00237	0.0135	CbGeAlD
Maprotiline—SLC6A2—brainstem—multiple sclerosis	0.00203	0.0116	CbGeAlD
Maprotiline—HTR7—brainstem—multiple sclerosis	0.00196	0.0112	CbGeAlD
Maprotiline—CHRM5—nervous system—multiple sclerosis	0.00193	0.011	CbGeAlD
Maprotiline—CHRM4—brain—multiple sclerosis	0.00188	0.0107	CbGeAlD
Maprotiline—CHRM5—central nervous system—multiple sclerosis	0.00185	0.0106	CbGeAlD
Maprotiline—DRD2—brainstem—multiple sclerosis	0.00185	0.0105	CbGeAlD
Maprotiline—DRD2—retina—multiple sclerosis	0.00178	0.0102	CbGeAlD
Maprotiline—HTR2C—medulla oblongata—multiple sclerosis	0.0017	0.00967	CbGeAlD
Maprotiline—ORM1—spinal cord—multiple sclerosis	0.00168	0.00959	CbGeAlD
Maprotiline—SLC6A3—midbrain—multiple sclerosis	0.0016	0.00914	CbGeAlD
Maprotiline—SLC6A3—spinal cord—multiple sclerosis	0.00156	0.00892	CbGeAlD
Maprotiline—HTR2C—midbrain—multiple sclerosis	0.00155	0.00884	CbGeAlD
Maprotiline—HTR2C—spinal cord—multiple sclerosis	0.00151	0.00862	CbGeAlD
Maprotiline—CHRM5—brain—multiple sclerosis	0.00147	0.00839	CbGeAlD
Maprotiline—ORM1—nervous system—multiple sclerosis	0.00142	0.00808	CbGeAlD
Maprotiline—SLC6A2—medulla oblongata—multiple sclerosis	0.00142	0.00807	CbGeAlD
Maprotiline—ORM1—central nervous system—multiple sclerosis	0.00136	0.00778	CbGeAlD
Maprotiline—HTR7—medulla oblongata—multiple sclerosis	0.00136	0.00778	CbGeAlD
Maprotiline—CHRM2—nervous system—multiple sclerosis	0.00132	0.00754	CbGeAlD
Maprotiline—SLC6A3—nervous system—multiple sclerosis	0.00132	0.00751	CbGeAlD
Maprotiline—HTR2C—nervous system—multiple sclerosis	0.00127	0.00726	CbGeAlD
Maprotiline—CHRM2—central nervous system—multiple sclerosis	0.00127	0.00726	CbGeAlD
Maprotiline—SLC6A3—central nervous system—multiple sclerosis	0.00127	0.00723	CbGeAlD
Maprotiline—HTR7—midbrain—multiple sclerosis	0.00125	0.00711	CbGeAlD
Maprotiline—SLC6A3—cerebellum—multiple sclerosis	0.00124	0.00707	CbGeAlD
Maprotiline—HTR2C—central nervous system—multiple sclerosis	0.00123	0.00699	CbGeAlD
Maprotiline—HTR2A—brainstem—multiple sclerosis	0.00122	0.00695	CbGeAlD
Maprotiline—HTR7—spinal cord—multiple sclerosis	0.00122	0.00693	CbGeAlD
Maprotiline—CHRM1—nervous system—multiple sclerosis	0.0012	0.00686	CbGeAlD
Maprotiline—DRD2—midbrain—multiple sclerosis	0.00118	0.00672	CbGeAlD
Maprotiline—HTR2A—retina—multiple sclerosis	0.00118	0.00671	CbGeAlD
Maprotiline—CHRM1—central nervous system—multiple sclerosis	0.00116	0.0066	CbGeAlD
Maprotiline—CYP2D6—brainstem—multiple sclerosis	0.00111	0.00634	CbGeAlD
Maprotiline—CHRM3—nervous system—multiple sclerosis	0.00108	0.00614	CbGeAlD
Maprotiline—SLC6A2—nervous system—multiple sclerosis	0.00106	0.00606	CbGeAlD
Maprotiline—CHRM3—central nervous system—multiple sclerosis	0.00104	0.00591	CbGeAlD
Maprotiline—HTR7—nervous system—multiple sclerosis	0.00103	0.00584	CbGeAlD
Maprotiline—SLC6A2—central nervous system—multiple sclerosis	0.00102	0.00584	CbGeAlD
Maprotiline—CHRM2—brain—multiple sclerosis	0.00101	0.00576	CbGeAlD
Maprotiline—SLC6A3—brain—multiple sclerosis	0.00101	0.00574	CbGeAlD
Maprotiline—HTR7—central nervous system—multiple sclerosis	0.000987	0.00563	CbGeAlD
Maprotiline—HTR2C—brain—multiple sclerosis	0.000974	0.00555	CbGeAlD
Maprotiline—DRD2—nervous system—multiple sclerosis	0.000969	0.00552	CbGeAlD
Maprotiline—HTR7—cerebellum—multiple sclerosis	0.000965	0.0055	CbGeAlD
Maprotiline—DRD2—central nervous system—multiple sclerosis	0.000933	0.00532	CbGeAlD
Maprotiline—CHRM1—brain—multiple sclerosis	0.00092	0.00524	CbGeAlD
Maprotiline—DRD2—cerebellum—multiple sclerosis	0.000912	0.0052	CbGeAlD
Maprotiline—HTR2A—medulla oblongata—multiple sclerosis	0.000851	0.00485	CbGeAlD
Maprotiline—CHRM3—brain—multiple sclerosis	0.000823	0.00469	CbGeAlD
Maprotiline—SLC6A2—brain—multiple sclerosis	0.000813	0.00463	CbGeAlD
Maprotiline—HTR7—brain—multiple sclerosis	0.000784	0.00447	CbGeAlD
Maprotiline—HTR2A—midbrain—multiple sclerosis	0.000778	0.00443	CbGeAlD
Maprotiline—ABCB1—retina—multiple sclerosis	0.000771	0.0044	CbGeAlD
Maprotiline—HRH1—nervous system—multiple sclerosis	0.000765	0.00436	CbGeAlD
Maprotiline—HTR2A—spinal cord—multiple sclerosis	0.000759	0.00432	CbGeAlD
Maprotiline—DRD2—brain—multiple sclerosis	0.000741	0.00422	CbGeAlD
Maprotiline—HRH1—central nervous system—multiple sclerosis	0.000737	0.0042	CbGeAlD
Maprotiline—HTR2A—nervous system—multiple sclerosis	0.000639	0.00364	CbGeAlD
Maprotiline—HTR2A—central nervous system—multiple sclerosis	0.000615	0.00351	CbGeAlD
Maprotiline—HTR2A—cerebellum—multiple sclerosis	0.000602	0.00343	CbGeAlD
Maprotiline—HRH1—brain—multiple sclerosis	0.000585	0.00333	CbGeAlD
Maprotiline—CYP2D6—nervous system—multiple sclerosis	0.000582	0.00332	CbGeAlD
Maprotiline—CYP2D6—central nervous system—multiple sclerosis	0.000561	0.0032	CbGeAlD
Maprotiline—ABCB1—medulla oblongata—multiple sclerosis	0.000558	0.00318	CbGeAlD
Maprotiline—CYP2D6—cerebellum—multiple sclerosis	0.000548	0.00312	CbGeAlD
Maprotiline—ABCB1—midbrain—multiple sclerosis	0.00051	0.0029	CbGeAlD
Maprotiline—ABCB1—spinal cord—multiple sclerosis	0.000497	0.00283	CbGeAlD
Maprotiline—HTR2A—brain—multiple sclerosis	0.000489	0.00279	CbGeAlD
Maprotiline—CYP2D6—brain—multiple sclerosis	0.000445	0.00254	CbGeAlD
Maprotiline—Arrhythmia—Dexamethasone—multiple sclerosis	0.000432	0.00121	CcSEcCtD
Maprotiline—Constipation—Mitoxantrone—multiple sclerosis	0.000429	0.0012	CcSEcCtD
Maprotiline—Alopecia—Dexamethasone—multiple sclerosis	0.000428	0.00119	CcSEcCtD
Maprotiline—Alopecia—Betamethasone—multiple sclerosis	0.000428	0.00119	CcSEcCtD
Maprotiline—Diarrhoea—Azathioprine—multiple sclerosis	0.000425	0.00118	CcSEcCtD
Maprotiline—Hallucination—Prednisone—multiple sclerosis	0.000419	0.00117	CcSEcCtD
Maprotiline—ABCB1—nervous system—multiple sclerosis	0.000419	0.00239	CbGeAlD
Maprotiline—Pancytopenia—Methotrexate—multiple sclerosis	0.000418	0.00116	CcSEcCtD
Maprotiline—Syncope—Triamcinolone—multiple sclerosis	0.000416	0.00116	CcSEcCtD
Maprotiline—Syncope—Methylprednisolone—multiple sclerosis	0.000415	0.00116	CcSEcCtD
Maprotiline—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000414	0.00115	CcSEcCtD
Maprotiline—Oedema—Prednisolone—multiple sclerosis	0.000412	0.00115	CcSEcCtD
Maprotiline—Dizziness—Azathioprine—multiple sclerosis	0.000411	0.00115	CcSEcCtD
Maprotiline—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000411	0.00114	CcSEcCtD
Maprotiline—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000408	0.00114	CcSEcCtD
Maprotiline—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000407	0.00113	CcSEcCtD
Maprotiline—Shock—Prednisolone—multiple sclerosis	0.000405	0.00113	CcSEcCtD
Maprotiline—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000405	0.00113	CcSEcCtD
Maprotiline—ABCB1—central nervous system—multiple sclerosis	0.000403	0.0023	CbGeAlD
Maprotiline—Convulsion—Triamcinolone—multiple sclerosis	0.000402	0.00112	CcSEcCtD
Maprotiline—Tachycardia—Prednisolone—multiple sclerosis	0.000402	0.00112	CcSEcCtD
Maprotiline—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000402	0.00112	CcSEcCtD
Maprotiline—Convulsion—Methylprednisolone—multiple sclerosis	0.000401	0.00112	CcSEcCtD
Maprotiline—Hypertension—Triamcinolone—multiple sclerosis	0.000401	0.00112	CcSEcCtD
Maprotiline—Hypertension—Methylprednisolone—multiple sclerosis	0.0004	0.00111	CcSEcCtD
Maprotiline—Urticaria—Mitoxantrone—multiple sclerosis	0.000399	0.00111	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000398	0.00111	CcSEcCtD
Maprotiline—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000397	0.00111	CcSEcCtD
Maprotiline—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000397	0.00111	CcSEcCtD
Maprotiline—Vomiting—Azathioprine—multiple sclerosis	0.000395	0.0011	CcSEcCtD
Maprotiline—ABCB1—cerebellum—multiple sclerosis	0.000394	0.00225	CbGeAlD
Maprotiline—Eye disorder—Prednisone—multiple sclerosis	0.000394	0.0011	CcSEcCtD
Maprotiline—Anxiety—Methylprednisolone—multiple sclerosis	0.000393	0.0011	CcSEcCtD
Maprotiline—Infestation—Methotrexate—multiple sclerosis	0.000392	0.00109	CcSEcCtD
Maprotiline—Drowsiness—Methotrexate—multiple sclerosis	0.000392	0.00109	CcSEcCtD
Maprotiline—Infestation NOS—Methotrexate—multiple sclerosis	0.000392	0.00109	CcSEcCtD
Maprotiline—Rash—Azathioprine—multiple sclerosis	0.000392	0.00109	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000392	0.00109	CcSEcCtD
Maprotiline—Dermatitis—Azathioprine—multiple sclerosis	0.000391	0.00109	CcSEcCtD
Maprotiline—Flushing—Prednisone—multiple sclerosis	0.000391	0.00109	CcSEcCtD
Maprotiline—Headache—Azathioprine—multiple sclerosis	0.000389	0.00108	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000389	0.00108	CcSEcCtD
Maprotiline—Dry mouth—Triamcinolone—multiple sclerosis	0.000386	0.00108	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—multiple sclerosis	0.000382	0.00107	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—multiple sclerosis	0.000382	0.00107	CcSEcCtD
Maprotiline—Confusional state—Methylprednisolone—multiple sclerosis	0.000381	0.00106	CcSEcCtD
Maprotiline—Oedema—Triamcinolone—multiple sclerosis	0.000379	0.00106	CcSEcCtD
Maprotiline—Syncope—Dexamethasone—multiple sclerosis	0.000378	0.00105	CcSEcCtD
Maprotiline—Syncope—Betamethasone—multiple sclerosis	0.000378	0.00105	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—multiple sclerosis	0.000376	0.00105	CcSEcCtD
Maprotiline—Infection—Triamcinolone—multiple sclerosis	0.000376	0.00105	CcSEcCtD
Maprotiline—Infection—Methylprednisolone—multiple sclerosis	0.000376	0.00105	CcSEcCtD
Maprotiline—Shock—Triamcinolone—multiple sclerosis	0.000373	0.00104	CcSEcCtD
Maprotiline—Insomnia—Prednisolone—multiple sclerosis	0.000373	0.00104	CcSEcCtD
Maprotiline—Alopecia—Prednisone—multiple sclerosis	0.000372	0.00104	CcSEcCtD
Maprotiline—Shock—Methylprednisolone—multiple sclerosis	0.000372	0.00104	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000371	0.00103	CcSEcCtD
Maprotiline—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000371	0.00103	CcSEcCtD
Maprotiline—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00037	0.00103	CcSEcCtD
Maprotiline—Loss of consciousness—Betamethasone—multiple sclerosis	0.00037	0.00103	CcSEcCtD
Maprotiline—Paraesthesia—Prednisolone—multiple sclerosis	0.00037	0.00103	CcSEcCtD
Maprotiline—Tachycardia—Triamcinolone—multiple sclerosis	0.00037	0.00103	CcSEcCtD
Maprotiline—Nausea—Azathioprine—multiple sclerosis	0.000369	0.00103	CcSEcCtD
Maprotiline—Tachycardia—Methylprednisolone—multiple sclerosis	0.000369	0.00103	CcSEcCtD
Maprotiline—Skin disorder—Methylprednisolone—multiple sclerosis	0.000367	0.00102	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—multiple sclerosis	0.000367	0.00102	CcSEcCtD
Maprotiline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000366	0.00102	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—multiple sclerosis	0.000366	0.00102	CcSEcCtD
Maprotiline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000365	0.00102	CcSEcCtD
Maprotiline—Convulsion—Dexamethasone—multiple sclerosis	0.000365	0.00102	CcSEcCtD
Maprotiline—Convulsion—Betamethasone—multiple sclerosis	0.000365	0.00102	CcSEcCtD
Maprotiline—Hypertension—Dexamethasone—multiple sclerosis	0.000364	0.00101	CcSEcCtD
Maprotiline—Hypertension—Betamethasone—multiple sclerosis	0.000364	0.00101	CcSEcCtD
Maprotiline—Asthenia—Mitoxantrone—multiple sclerosis	0.00036	0.001	CcSEcCtD
Maprotiline—Anxiety—Dexamethasone—multiple sclerosis	0.000357	0.000996	CcSEcCtD
Maprotiline—Anxiety—Betamethasone—multiple sclerosis	0.000357	0.000996	CcSEcCtD
Maprotiline—Hypotension—Methylprednisolone—multiple sclerosis	0.000353	0.000985	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—multiple sclerosis	0.000352	0.000982	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000348	0.00097	CcSEcCtD
Maprotiline—Vision blurred—Prednisone—multiple sclerosis	0.000346	0.000964	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—multiple sclerosis	0.000345	0.000962	CcSEcCtD
Maprotiline—Oedema—Dexamethasone—multiple sclerosis	0.000344	0.000958	CcSEcCtD
Maprotiline—Oedema—Betamethasone—multiple sclerosis	0.000344	0.000958	CcSEcCtD
Maprotiline—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000344	0.000958	CcSEcCtD
Maprotiline—Insomnia—Triamcinolone—multiple sclerosis	0.000343	0.000955	CcSEcCtD
Maprotiline—Insomnia—Methylprednisolone—multiple sclerosis	0.000342	0.000953	CcSEcCtD
Maprotiline—Infection—Dexamethasone—multiple sclerosis	0.000341	0.000952	CcSEcCtD
Maprotiline—Infection—Betamethasone—multiple sclerosis	0.000341	0.000952	CcSEcCtD
Maprotiline—Paraesthesia—Triamcinolone—multiple sclerosis	0.00034	0.000948	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisolone—multiple sclerosis	0.000339	0.000947	CcSEcCtD
Maprotiline—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000339	0.000946	CcSEcCtD
Maprotiline—Shock—Betamethasone—multiple sclerosis	0.000338	0.000943	CcSEcCtD
Maprotiline—Shock—Dexamethasone—multiple sclerosis	0.000338	0.000943	CcSEcCtD
Maprotiline—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000337	0.00094	CcSEcCtD
Maprotiline—Nervous system disorder—Betamethasone—multiple sclerosis	0.000337	0.00094	CcSEcCtD
Maprotiline—Agitation—Prednisone—multiple sclerosis	0.000337	0.00094	CcSEcCtD
Maprotiline—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000337	0.000938	CcSEcCtD
Maprotiline—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000337	0.000938	CcSEcCtD
Maprotiline—Tachycardia—Dexamethasone—multiple sclerosis	0.000335	0.000935	CcSEcCtD
Maprotiline—Tachycardia—Betamethasone—multiple sclerosis	0.000335	0.000935	CcSEcCtD
Maprotiline—Dyspepsia—Triamcinolone—multiple sclerosis	0.000333	0.00093	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—multiple sclerosis	0.000333	0.000928	CcSEcCtD
Maprotiline—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000333	0.000928	CcSEcCtD
Maprotiline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000332	0.000927	CcSEcCtD
Maprotiline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000332	0.000927	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—multiple sclerosis	0.000329	0.000918	CcSEcCtD
Maprotiline—Syncope—Prednisone—multiple sclerosis	0.000329	0.000917	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—multiple sclerosis	0.000328	0.000915	CcSEcCtD
Maprotiline—Urticaria—Prednisolone—multiple sclerosis	0.000327	0.000912	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—multiple sclerosis	0.000327	0.000911	CcSEcCtD
Maprotiline—Fatigue—Triamcinolone—multiple sclerosis	0.000327	0.000911	CcSEcCtD
Maprotiline—Fatigue—Methylprednisolone—multiple sclerosis	0.000326	0.000909	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—multiple sclerosis	0.000322	0.000899	CcSEcCtD
Maprotiline—Hypotension—Dexamethasone—multiple sclerosis	0.000321	0.000896	CcSEcCtD
Maprotiline—Hypotension—Betamethasone—multiple sclerosis	0.000321	0.000896	CcSEcCtD
Maprotiline—ABCB1—brain—multiple sclerosis	0.00032	0.00183	CbGeAlD
Maprotiline—Angiopathy—Methotrexate—multiple sclerosis	0.000319	0.000891	CcSEcCtD
Maprotiline—Vomiting—Mitoxantrone—multiple sclerosis	0.000319	0.00089	CcSEcCtD
Maprotiline—Convulsion—Prednisone—multiple sclerosis	0.000318	0.000886	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000317	0.000885	CcSEcCtD
Maprotiline—Hypertension—Prednisone—multiple sclerosis	0.000317	0.000883	CcSEcCtD
Maprotiline—Rash—Mitoxantrone—multiple sclerosis	0.000317	0.000883	CcSEcCtD
Maprotiline—Dermatitis—Mitoxantrone—multiple sclerosis	0.000316	0.000882	CcSEcCtD
Maprotiline—Headache—Mitoxantrone—multiple sclerosis	0.000315	0.000877	CcSEcCtD
Maprotiline—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000312	0.00087	CcSEcCtD
Maprotiline—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000311	0.000868	CcSEcCtD
Maprotiline—Anxiety—Prednisone—multiple sclerosis	0.000311	0.000868	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—multiple sclerosis	0.000311	0.000868	CcSEcCtD
Maprotiline—Insomnia—Betamethasone—multiple sclerosis	0.000311	0.000867	CcSEcCtD
Maprotiline—Insomnia—Dexamethasone—multiple sclerosis	0.000311	0.000867	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00031	0.000865	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000309	0.000862	CcSEcCtD
Maprotiline—Paraesthesia—Dexamethasone—multiple sclerosis	0.000309	0.000861	CcSEcCtD
Maprotiline—Paraesthesia—Betamethasone—multiple sclerosis	0.000309	0.000861	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—multiple sclerosis	0.000307	0.000855	CcSEcCtD
Maprotiline—Dyspepsia—Dexamethasone—multiple sclerosis	0.000303	0.000844	CcSEcCtD
Maprotiline—Dyspepsia—Betamethasone—multiple sclerosis	0.000303	0.000844	CcSEcCtD
Maprotiline—Urticaria—Triamcinolone—multiple sclerosis	0.000301	0.000839	CcSEcCtD
Maprotiline—Urticaria—Methylprednisolone—multiple sclerosis	0.0003	0.000837	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—multiple sclerosis	0.0003	0.000837	CcSEcCtD
Maprotiline—Body temperature increased—Triamcinolone—multiple sclerosis	0.000299	0.000835	CcSEcCtD
Maprotiline—Oedema—Prednisone—multiple sclerosis	0.000299	0.000835	CcSEcCtD
Maprotiline—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000299	0.000833	CcSEcCtD
Maprotiline—Nausea—Mitoxantrone—multiple sclerosis	0.000298	0.000832	CcSEcCtD
Maprotiline—Infection—Prednisone—multiple sclerosis	0.000297	0.000829	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000297	0.000827	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000297	0.000827	CcSEcCtD
Maprotiline—Fatigue—Betamethasone—multiple sclerosis	0.000296	0.000826	CcSEcCtD
Maprotiline—Fatigue—Dexamethasone—multiple sclerosis	0.000296	0.000826	CcSEcCtD
Maprotiline—Shock—Prednisone—multiple sclerosis	0.000295	0.000821	CcSEcCtD
Maprotiline—Nervous system disorder—Prednisone—multiple sclerosis	0.000294	0.000819	CcSEcCtD
Maprotiline—Tachycardia—Prednisone—multiple sclerosis	0.000292	0.000815	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—multiple sclerosis	0.000291	0.000811	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—multiple sclerosis	0.000289	0.000807	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—multiple sclerosis	0.000289	0.000805	CcSEcCtD
Maprotiline—Feeling abnormal—Betamethasone—multiple sclerosis	0.000283	0.00079	CcSEcCtD
Maprotiline—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000283	0.00079	CcSEcCtD
Maprotiline—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000281	0.000784	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000281	0.000784	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—multiple sclerosis	0.000274	0.000765	CcSEcCtD
Maprotiline—Urticaria—Betamethasone—multiple sclerosis	0.000273	0.000761	CcSEcCtD
Maprotiline—Urticaria—Dexamethasone—multiple sclerosis	0.000273	0.000761	CcSEcCtD
Maprotiline—Dizziness—Prednisolone—multiple sclerosis	0.000272	0.00076	CcSEcCtD
Maprotiline—Asthenia—Triamcinolone—multiple sclerosis	0.000272	0.000758	CcSEcCtD
Maprotiline—Abdominal pain—Betamethasone—multiple sclerosis	0.000272	0.000758	CcSEcCtD
Maprotiline—Abdominal pain—Dexamethasone—multiple sclerosis	0.000272	0.000758	CcSEcCtD
Maprotiline—Body temperature increased—Dexamethasone—multiple sclerosis	0.000272	0.000758	CcSEcCtD
Maprotiline—Body temperature increased—Betamethasone—multiple sclerosis	0.000272	0.000758	CcSEcCtD
Maprotiline—Asthenia—Methylprednisolone—multiple sclerosis	0.000271	0.000756	CcSEcCtD
Maprotiline—Insomnia—Prednisone—multiple sclerosis	0.000271	0.000755	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—multiple sclerosis	0.000269	0.000749	CcSEcCtD
Maprotiline—Pruritus—Triamcinolone—multiple sclerosis	0.000268	0.000747	CcSEcCtD
Maprotiline—Pruritus—Methylprednisolone—multiple sclerosis	0.000267	0.000746	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—multiple sclerosis	0.000266	0.000741	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—multiple sclerosis	0.000263	0.000735	CcSEcCtD
Maprotiline—Rash—Prednisolone—multiple sclerosis	0.00026	0.000724	CcSEcCtD
Maprotiline—Dermatitis—Prednisolone—multiple sclerosis	0.000259	0.000724	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000259	0.000723	CcSEcCtD
Maprotiline—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000259	0.000721	CcSEcCtD
Maprotiline—Fatigue—Prednisone—multiple sclerosis	0.000258	0.00072	CcSEcCtD
Maprotiline—Headache—Prednisolone—multiple sclerosis	0.000258	0.00072	CcSEcCtD
Maprotiline—Constipation—Prednisone—multiple sclerosis	0.000256	0.000714	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—multiple sclerosis	0.000252	0.000703	CcSEcCtD
Maprotiline—Dizziness—Triamcinolone—multiple sclerosis	0.000251	0.000698	CcSEcCtD
Maprotiline—Dizziness—Methylprednisolone—multiple sclerosis	0.00025	0.000697	CcSEcCtD
Maprotiline—Infection—Methotrexate—multiple sclerosis	0.000249	0.000693	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—multiple sclerosis	0.000247	0.000688	CcSEcCtD
Maprotiline—Asthenia—Betamethasone—multiple sclerosis	0.000247	0.000688	CcSEcCtD
Maprotiline—Asthenia—Dexamethasone—multiple sclerosis	0.000247	0.000688	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—multiple sclerosis	0.000245	0.000684	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000245	0.000683	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000245	0.000683	CcSEcCtD
Maprotiline—Nausea—Prednisolone—multiple sclerosis	0.000245	0.000682	CcSEcCtD
Maprotiline—Pruritus—Dexamethasone—multiple sclerosis	0.000243	0.000678	CcSEcCtD
Maprotiline—Pruritus—Betamethasone—multiple sclerosis	0.000243	0.000678	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—multiple sclerosis	0.000243	0.000678	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000242	0.000674	CcSEcCtD
Maprotiline—Vomiting—Triamcinolone—multiple sclerosis	0.000241	0.000672	CcSEcCtD
Maprotiline—Vomiting—Methylprednisolone—multiple sclerosis	0.00024	0.00067	CcSEcCtD
Maprotiline—Rash—Triamcinolone—multiple sclerosis	0.000239	0.000666	CcSEcCtD
Maprotiline—Dermatitis—Triamcinolone—multiple sclerosis	0.000239	0.000665	CcSEcCtD
Maprotiline—Rash—Methylprednisolone—multiple sclerosis	0.000238	0.000665	CcSEcCtD
Maprotiline—Dermatitis—Methylprednisolone—multiple sclerosis	0.000238	0.000664	CcSEcCtD
Maprotiline—Urticaria—Prednisone—multiple sclerosis	0.000238	0.000663	CcSEcCtD
Maprotiline—Headache—Triamcinolone—multiple sclerosis	0.000237	0.000662	CcSEcCtD
Maprotiline—Headache—Methylprednisolone—multiple sclerosis	0.000237	0.00066	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—multiple sclerosis	0.000237	0.00066	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—multiple sclerosis	0.000237	0.00066	CcSEcCtD
Maprotiline—Diarrhoea—Dexamethasone—multiple sclerosis	0.000235	0.000656	CcSEcCtD
Maprotiline—Diarrhoea—Betamethasone—multiple sclerosis	0.000235	0.000656	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—multiple sclerosis	0.000234	0.000652	CcSEcCtD
Maprotiline—Dizziness—Dexamethasone—multiple sclerosis	0.000227	0.000634	CcSEcCtD
Maprotiline—Dizziness—Betamethasone—multiple sclerosis	0.000227	0.000634	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—multiple sclerosis	0.000226	0.000631	CcSEcCtD
Maprotiline—Nausea—Triamcinolone—multiple sclerosis	0.000225	0.000627	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—multiple sclerosis	0.000225	0.000626	CcSEcCtD
Maprotiline—Nausea—Methylprednisolone—multiple sclerosis	0.000225	0.000626	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—multiple sclerosis	0.000222	0.00062	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—multiple sclerosis	0.00022	0.000614	CcSEcCtD
Maprotiline—Vomiting—Dexamethasone—multiple sclerosis	0.000219	0.000609	CcSEcCtD
Maprotiline—Vomiting—Betamethasone—multiple sclerosis	0.000219	0.000609	CcSEcCtD
Maprotiline—Rash—Betamethasone—multiple sclerosis	0.000217	0.000604	CcSEcCtD
Maprotiline—Rash—Dexamethasone—multiple sclerosis	0.000217	0.000604	CcSEcCtD
Maprotiline—Dermatitis—Betamethasone—multiple sclerosis	0.000217	0.000604	CcSEcCtD
Maprotiline—Dermatitis—Dexamethasone—multiple sclerosis	0.000217	0.000604	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000216	0.000602	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—multiple sclerosis	0.000216	0.000601	CcSEcCtD
Maprotiline—Headache—Dexamethasone—multiple sclerosis	0.000215	0.0006	CcSEcCtD
Maprotiline—Headache—Betamethasone—multiple sclerosis	0.000215	0.0006	CcSEcCtD
Maprotiline—Asthenia—Prednisone—multiple sclerosis	0.000215	0.000599	CcSEcCtD
Maprotiline—Pruritus—Prednisone—multiple sclerosis	0.000212	0.000591	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—multiple sclerosis	0.000206	0.000575	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—multiple sclerosis	0.000205	0.000571	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000205	0.00057	CcSEcCtD
Maprotiline—Nausea—Dexamethasone—multiple sclerosis	0.000204	0.000569	CcSEcCtD
Maprotiline—Nausea—Betamethasone—multiple sclerosis	0.000204	0.000569	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—multiple sclerosis	0.000199	0.000554	CcSEcCtD
Maprotiline—Dizziness—Prednisone—multiple sclerosis	0.000198	0.000552	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—multiple sclerosis	0.000198	0.000551	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—multiple sclerosis	0.000198	0.000551	CcSEcCtD
Maprotiline—Vomiting—Prednisone—multiple sclerosis	0.00019	0.000531	CcSEcCtD
Maprotiline—Rash—Prednisone—multiple sclerosis	0.000189	0.000526	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—multiple sclerosis	0.000189	0.000526	CcSEcCtD
Maprotiline—Headache—Prednisone—multiple sclerosis	0.000188	0.000523	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—multiple sclerosis	0.000179	0.0005	CcSEcCtD
Maprotiline—Nausea—Prednisone—multiple sclerosis	0.000178	0.000496	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—multiple sclerosis	0.000177	0.000494	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—multiple sclerosis	0.000171	0.000477	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—multiple sclerosis	0.000165	0.000461	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—multiple sclerosis	0.000159	0.000444	CcSEcCtD
Maprotiline—Rash—Methotrexate—multiple sclerosis	0.000158	0.00044	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—multiple sclerosis	0.000158	0.000439	CcSEcCtD
Maprotiline—Headache—Methotrexate—multiple sclerosis	0.000157	0.000437	CcSEcCtD
Maprotiline—Nausea—Methotrexate—multiple sclerosis	0.000149	0.000414	CcSEcCtD
Maprotiline—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	2.73e-05	0.000177	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CNR1—multiple sclerosis	2.73e-05	0.000177	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	2.72e-05	0.000177	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	2.72e-05	0.000177	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	2.72e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.71e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.71e-05	0.000175	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	2.7e-05	0.000175	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	2.68e-05	0.000174	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.68e-05	0.000174	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CNR1—multiple sclerosis	2.68e-05	0.000174	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	2.67e-05	0.000173	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APOE—multiple sclerosis	2.66e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.66e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	2.65e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.63e-05	0.000171	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	2.61e-05	0.000169	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	2.59e-05	0.000168	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	2.54e-05	0.000164	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—POMC—multiple sclerosis	2.52e-05	0.000163	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APOE—multiple sclerosis	2.51e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	2.48e-05	0.000161	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—POMC—multiple sclerosis	2.47e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.46e-05	0.00016	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	2.46e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.46e-05	0.000159	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	2.45e-05	0.000159	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.43e-05	0.000158	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CD86—multiple sclerosis	2.43e-05	0.000158	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	2.42e-05	0.000157	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	2.42e-05	0.000157	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	2.42e-05	0.000157	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.41e-05	0.000156	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	2.41e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APOE—multiple sclerosis	2.41e-05	0.000156	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CD80—multiple sclerosis	2.41e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.4e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.4e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.39e-05	0.000155	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	2.39e-05	0.000155	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.38e-05	0.000154	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.37e-05	0.000154	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	2.32e-05	0.000151	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.3e-05	0.000149	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—POMC—multiple sclerosis	2.29e-05	0.000148	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CD80—multiple sclerosis	2.27e-05	0.000147	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	2.24e-05	0.000145	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCL2—multiple sclerosis	2.24e-05	0.000145	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	2.22e-05	0.000144	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	2.2e-05	0.000143	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	2.2e-05	0.000142	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	2.19e-05	0.000142	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	2.19e-05	0.000142	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	2.18e-05	0.000142	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CD80—multiple sclerosis	2.18e-05	0.000141	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	2.16e-05	0.00014	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—POMC—multiple sclerosis	2.16e-05	0.00014	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	2.16e-05	0.00014	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CD86—multiple sclerosis	2.15e-05	0.000139	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.14e-05	0.000139	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—BCHE—multiple sclerosis	2.13e-05	0.000138	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	2.13e-05	0.000138	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL5—multiple sclerosis	2.11e-05	0.000137	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	2.11e-05	0.000137	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CD86—multiple sclerosis	2.11e-05	0.000137	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	2.11e-05	0.000137	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CD86—multiple sclerosis	2.11e-05	0.000137	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CD86—multiple sclerosis	2.1e-05	0.000136	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CD86—multiple sclerosis	2.09e-05	0.000136	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	2.08e-05	0.000135	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL5—multiple sclerosis	2.07e-05	0.000135	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CD86—multiple sclerosis	2.07e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—POMC—multiple sclerosis	2.07e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	2.07e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	2.07e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	2.06e-05	0.000134	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	2.05e-05	0.000133	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	2.04e-05	0.000132	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TYK2—multiple sclerosis	2.03e-05	0.000132	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	2.02e-05	0.000131	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOE—multiple sclerosis	2.02e-05	0.000131	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	2.02e-05	0.000131	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	2.01e-05	0.000131	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.01e-05	0.00013	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.01e-05	0.00013	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	2e-05	0.00013	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.98e-05	0.000128	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	1.98e-05	0.000128	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.97e-05	0.000128	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.96e-05	0.000127	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.96e-05	0.000127	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.93e-05	0.000125	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.92e-05	0.000125	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	1.92e-05	0.000124	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.92e-05	0.000124	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.91e-05	0.000124	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.9e-05	0.000123	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.89e-05	0.000123	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.88e-05	0.000122	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.87e-05	0.000121	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.87e-05	0.000121	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.86e-05	0.000121	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.86e-05	0.000121	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.86e-05	0.00012	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.85e-05	0.00012	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.84e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.84e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	1.84e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.84e-05	0.000119	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.83e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.83e-05	0.000119	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.83e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.82e-05	0.000118	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.82e-05	0.000118	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.81e-05	0.000118	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.8e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.8e-05	0.000117	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.77e-05	0.000115	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—multiple sclerosis	1.74e-05	0.000113	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.73e-05	0.000112	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.7e-05	0.000111	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.00011	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.7e-05	0.00011	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.69e-05	0.00011	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.69e-05	0.00011	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.69e-05	0.00011	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.69e-05	0.000109	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.68e-05	0.000109	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.67e-05	0.000109	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.65e-05	0.000107	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.61e-05	0.000105	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.6e-05	0.000104	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2—multiple sclerosis	1.6e-05	0.000104	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	1.59e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—multiple sclerosis	1.58e-05	0.000103	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.57e-05	0.000102	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.54e-05	9.99e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.54e-05	9.97e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.53e-05	9.94e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.53e-05	9.92e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.53e-05	9.91e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.52e-05	9.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.51e-05	9.81e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.51e-05	9.8e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.5e-05	9.71e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.49e-05	9.65e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.46e-05	9.49e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.46e-05	9.47e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.46e-05	9.44e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.46e-05	9.44e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.45e-05	9.41e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.45e-05	9.38e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.44e-05	9.32e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.43e-05	9.29e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.43e-05	9.27e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.42e-05	9.24e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.42e-05	9.24e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.42e-05	9.23e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.42e-05	9.21e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.41e-05	9.12e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.4e-05	9.09e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.4e-05	9.07e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.39e-05	9.04e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.39e-05	9.01e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.38e-05	8.92e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.34e-05	8.71e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—multiple sclerosis	1.32e-05	8.57e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.32e-05	8.57e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	1.32e-05	8.55e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.3e-05	8.44e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.3e-05	8.42e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.29e-05	8.39e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	1.29e-05	8.39e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.29e-05	8.36e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.29e-05	8.34e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—multiple sclerosis	1.28e-05	8.31e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.28e-05	8.28e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.25e-05	8.1e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.25e-05	8.08e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.25e-05	8.08e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.24e-05	8.04e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.22e-05	7.92e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—multiple sclerosis	1.21e-05	7.84e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.2e-05	7.75e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.19e-05	7.73e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.18e-05	7.65e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.17e-05	7.58e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—multiple sclerosis	1.1e-05	7.14e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.1e-05	7.13e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.09e-05	7.1e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.08e-05	7.02e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.08e-05	7e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.08e-05	6.98e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.08e-05	6.98e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	6.97e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.07e-05	6.96e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	6.95e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	6.92e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.06e-05	6.89e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.06e-05	6.86e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	1.05e-05	6.8e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.04e-05	6.75e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—multiple sclerosis	1.04e-05	6.73e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	6.64e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—multiple sclerosis	1.02e-05	6.64e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	6.63e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	6.61e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	6.59e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.01e-05	6.52e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—multiple sclerosis	1e-05	6.51e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—multiple sclerosis	9.94e-06	6.44e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—multiple sclerosis	9.74e-06	6.32e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	9.72e-06	6.3e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	9.53e-06	6.18e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—multiple sclerosis	9.46e-06	6.14e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—multiple sclerosis	9.38e-06	6.09e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—multiple sclerosis	9.25e-06	6e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	9.11e-06	5.91e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—multiple sclerosis	9.09e-06	5.89e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	9.06e-06	5.87e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	9.03e-06	5.86e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—multiple sclerosis	8.99e-06	5.83e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	8.94e-06	5.8e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—multiple sclerosis	8.79e-06	5.7e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—multiple sclerosis	8.6e-06	5.58e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	8.58e-06	5.56e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—multiple sclerosis	8.46e-06	5.49e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—multiple sclerosis	8.44e-06	5.48e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	8.44e-06	5.47e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	8.42e-06	5.46e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—multiple sclerosis	8.42e-06	5.46e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	8.41e-06	5.46e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	8.4e-06	5.45e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—multiple sclerosis	8.39e-06	5.44e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	8.37e-06	5.43e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—multiple sclerosis	8.31e-06	5.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	8.29e-06	5.38e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	8.28e-06	5.37e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	8.26e-06	5.36e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	8.23e-06	5.34e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	8.21e-06	5.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	8.13e-06	5.27e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—multiple sclerosis	8.02e-06	5.2e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—multiple sclerosis	7.32e-06	4.75e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—multiple sclerosis	6.46e-06	4.19e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—multiple sclerosis	6.36e-06	4.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—multiple sclerosis	6.35e-06	4.12e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—multiple sclerosis	6.33e-06	4.1e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—multiple sclerosis	6.31e-06	4.09e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—multiple sclerosis	6.25e-06	4.05e-05	CbGpPWpGaD
